Cumberland Pharmaceuticals (CPIX) Competitors $3.23 -0.05 (-1.52%) Closing price 04:00 PM EasternExtended Trading$3.24 +0.01 (+0.43%) As of 04:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CPIX vs. ASMB, LLY, JNJ, ABBV, MRK, PFE, BMY, ZTS, RPRX, and CORTShould you be buying Cumberland Pharmaceuticals stock or one of its competitors? The main competitors of Cumberland Pharmaceuticals include Assembly Biosciences (ASMB), Eli Lilly and Company (LLY), Johnson & Johnson (JNJ), AbbVie (ABBV), Merck & Co., Inc. (MRK), Pfizer (PFE), Bristol Myers Squibb (BMY), Zoetis (ZTS), Royalty Pharma (RPRX), and Corcept Therapeutics (CORT). These companies are all part of the "pharmaceuticals" industry. Cumberland Pharmaceuticals vs. Its Competitors Assembly Biosciences Eli Lilly and Company Johnson & Johnson AbbVie Merck & Co., Inc. Pfizer Bristol Myers Squibb Zoetis Royalty Pharma Corcept Therapeutics Assembly Biosciences (NASDAQ:ASMB) and Cumberland Pharmaceuticals (NASDAQ:CPIX) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, institutional ownership, risk, profitability and earnings. Does the media favor ASMB or CPIX? In the previous week, Assembly Biosciences had 2 more articles in the media than Cumberland Pharmaceuticals. MarketBeat recorded 10 mentions for Assembly Biosciences and 8 mentions for Cumberland Pharmaceuticals. Assembly Biosciences' average media sentiment score of 0.51 beat Cumberland Pharmaceuticals' score of 0.45 indicating that Assembly Biosciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Assembly Biosciences 3 Very Positive mention(s) 0 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cumberland Pharmaceuticals 2 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Is ASMB or CPIX more profitable? Cumberland Pharmaceuticals has a net margin of -6.97% compared to Assembly Biosciences' net margin of -117.20%. Cumberland Pharmaceuticals' return on equity of 7.68% beat Assembly Biosciences' return on equity.Company Net Margins Return on Equity Return on Assets Assembly Biosciences-117.20% -135.14% -36.71% Cumberland Pharmaceuticals -6.97%7.68%2.60% Which has more risk & volatility, ASMB or CPIX? Assembly Biosciences has a beta of 0.64, indicating that its stock price is 36% less volatile than the S&P 500. Comparatively, Cumberland Pharmaceuticals has a beta of -0.39, indicating that its stock price is 139% less volatile than the S&P 500. Which has higher valuation & earnings, ASMB or CPIX? Cumberland Pharmaceuticals has higher revenue and earnings than Assembly Biosciences. Cumberland Pharmaceuticals is trading at a lower price-to-earnings ratio than Assembly Biosciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAssembly Biosciences$32.15M5.69-$40.18M-$5.58-4.30Cumberland Pharmaceuticals$42.07M1.15-$6.48M-$0.22-14.68 Do insiders & institutionals believe in ASMB or CPIX? 19.9% of Assembly Biosciences shares are owned by institutional investors. Comparatively, 15.5% of Cumberland Pharmaceuticals shares are owned by institutional investors. 5.3% of Assembly Biosciences shares are owned by insiders. Comparatively, 44.8% of Cumberland Pharmaceuticals shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Do analysts recommend ASMB or CPIX? Assembly Biosciences currently has a consensus price target of $33.00, indicating a potential upside of 37.67%. Given Assembly Biosciences' stronger consensus rating and higher probable upside, analysts clearly believe Assembly Biosciences is more favorable than Cumberland Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Assembly Biosciences 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.67Cumberland Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryAssembly Biosciences beats Cumberland Pharmaceuticals on 9 of the 16 factors compared between the two stocks. Get Cumberland Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CPIX and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CPIX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CPIX vs. The Competition Export to ExcelMetricCumberland PharmaceuticalsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$48.32M$2.41B$5.45B$9.68BDividend YieldN/A1.78%3.99%4.14%P/E Ratio-14.6820.1730.1125.01Price / Sales1.15444.85379.5578.79Price / Cash12.48165.0335.9458.58Price / Book2.014.128.135.68Net Income-$6.48M$31.61M$3.26B$265.68M7 Day Performance-8.24%0.46%1.15%2.51%1 Month Performance5.21%2.42%2.81%1.88%1 Year Performance129.08%4.45%28.41%24.00% Cumberland Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CPIXCumberland Pharmaceuticals1.0262 of 5 stars$3.23-1.5%N/A+121.6%$48.32M$42.07M-14.6880Earnings ReportGap DownASMBAssembly Biosciences3.7518 of 5 stars$19.40+5.4%$33.00+70.1%+68.1%$140.53M$32.15M-3.11100Earnings ReportUpcoming EarningsGap UpLLYEli Lilly and Company4.9719 of 5 stars$767.75+0.7%$1,012.56+31.9%-17.1%$722.49B$45.04B62.4747,000Trending NewsEarnings ReportAnalyst DowngradeGap UpJNJJohnson & Johnson4.6882 of 5 stars$171.08+2.2%$174.50+2.0%+7.9%$402.99B$88.82B18.30138,100Positive NewsABBVAbbVie4.6841 of 5 stars$197.05+0.9%$212.81+8.0%+6.0%$344.84B$56.33B93.8355,000Trending NewsAnalyst UpgradeInsider TradeMRKMerck & Co., Inc.4.9978 of 5 stars$79.93+0.8%$107.44+34.4%-28.6%$199.10B$64.17B12.3275,000Positive NewsPFEPfizer4.9867 of 5 stars$23.56+0.3%$28.28+20.0%-15.9%$133.55B$62.46B17.0781,000Trending NewsEarnings ReportAnalyst ForecastAnalyst RevisionBMYBristol Myers Squibb4.6268 of 5 stars$45.39+2.6%$57.33+26.3%-2.5%$90.01B$47.70B18.3034,100Positive NewsAnalyst DowngradeZTSZoetis4.8072 of 5 stars$152.31+3.3%$204.63+34.3%-19.9%$65.61B$9.26B27.3413,800Positive NewsEarnings ReportAnalyst RevisionRPRXRoyalty Pharma4.9334 of 5 stars$37.88+2.1%$49.00+29.4%+35.8%$20.86B$2.26B20.4880Earnings ReportCORTCorcept Therapeutics4.6518 of 5 stars$71.77+4.0%$134.50+87.4%+109.9%$7.32B$675.04M63.51300Insider Trade Related Companies and Tools Related Companies ASMB Alternatives LLY Alternatives JNJ Alternatives ABBV Alternatives MRK Alternatives PFE Alternatives BMY Alternatives ZTS Alternatives RPRX Alternatives CORT Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CPIX) was last updated on 8/8/2025 by MarketBeat.com Staff From Our PartnersTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredCrypto bros: Meet your replacementLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredFormer CIA Officer Reveals How Gold Saved His Life This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredHow high will gold surge?Weiss Gold Veteran Makes Shocking New Call Weiss expert Sean Brodrick went out on a limb last year and decl...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cumberland Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cumberland Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CPIX Stock Alerts